20.91
price up icon4.81%   0.96
after-market Handel nachbörslich: 20.91
loading

Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten

pulisher
Oct 22, 2024

Zenas Bio: Recent IPO With Late-Stage Candidate (NASDAQ:ZBIO) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 08, 2024

Zenas started at buy by four banks on lead drug potential (NASDAQ:ZBIO) - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Zenas stock backed by Guggenheim on strong outlook for lead drug obexelimab - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Morgan Stanley bullish on Zenas Biopharma stock as obexelimab trials gain momentum - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Citi sees upside in Zenas Biopharma stock as obexelimab progresses in key trials - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Jefferies bullish on Zenas stock as obexelimab advances in autoimmune trials - Investing.com Canada

Oct 08, 2024
pulisher
Oct 04, 2024

Biopharma financings surge to $86.2B in 2024, with $8.7B in September - BioWorld Online

Oct 04, 2024
pulisher
Oct 01, 2024

Halda appoints new chief executive - The Pharma Letter

Oct 01, 2024
pulisher
Sep 27, 2024

IgG4-related Disease Market to Show Remarkable Growth Trends - openPR

Sep 27, 2024
pulisher
Sep 22, 2024

Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.

Sep 22, 2024
pulisher
Sep 21, 2024

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

Sep 21, 2024
pulisher
Sep 21, 2024

Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle

Sep 20, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - The Korea Bizwire

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase ... - The Bakersfield Californian

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in - EIN News

Sep 19, 2024
pulisher
Sep 19, 2024

Upstream Bio goes public amid spate of IPOs - The Pharma Letter

Sep 19, 2024
pulisher
Sep 18, 2024

Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com South Africa

Sep 18, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com South Africa

Sep 17, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

IPOs, GLP-1 vs. PD-1, and AI in biotech: a BioCentury podcast - BioCentury

Sep 17, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director Jason Raleigh acquires $15 million in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Australia

Sep 16, 2024
pulisher
Sep 16, 2024

MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip

Sep 16, 2024
pulisher
Sep 14, 2024

Biotech IPO Shares Climb in Trading Debuts After Deals Upsized - MSN

Sep 14, 2024
pulisher
Sep 14, 2024

Biotech IPO Shares Climb in Trading Debuts After Deals Upsized | Stock Market News - Mint

Sep 14, 2024
pulisher
Sep 13, 2024

Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News

Sep 13, 2024
pulisher
Sep 13, 2024

Trio of first-day pops may bode well for biotech IPO window - BioCentury

Sep 13, 2024
pulisher
Sep 13, 2024

Biotech Startups Make Pre-Election Sprint to the Public Markets - The Wall Street Journal

Sep 13, 2024
pulisher
Sep 13, 2024

2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360

Sep 13, 2024
pulisher
Sep 13, 2024

Biotech trio revives the IPO market - Axios

Sep 13, 2024
pulisher
Sep 13, 2024

3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News

Sep 13, 2024
pulisher
Sep 13, 2024

Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals

Sep 13, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):